Literature DB >> 25601340

Dose escalation in lung cancer: have we gone full circle?

Corinne Faivre-Finn1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25601340     DOI： 10.1016/S1470-2045(15)70001-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  11 in total

1.  Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.

Authors:  Peter G Hawkins; Yilun Sun; Robert T Dess; William C Jackson; Grace Sun; Nan Bi; Muneesh Tewari; James A Hayman; Gregory P Kalemkerian; Shirish M Gadgeel; Theodore S Lawrence; Randall K Ten Haken; Martha M Matuszak; Feng-Ming Spring Kong; Matthew J Schipper; Shruti Jolly
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-28       Impact factor: 4.553

2.  Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET).

Authors:  K Harrington; E Hall; M Hawkins; A Henry; R MacKay; T Maughan; A McDonald; C Nutting; U Oelfke; D Sebag-Montefiore; R A Sharma; M van Herk; C Faivre-Finn
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-08-12       Impact factor: 4.126

3.  Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.

Authors:  M Trovo; N Giaj-Levra; C Furlan; M T Bortolin; E Muraro; J Polesel; E Minatel; R Tedeschi; A R Filippi; F Alongi; U Ricardi
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

4.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Robert T Dess; Yilun Sun; Martha M Matuszak; Grace Sun; Payal D Soni; Latifa Bazzi; Venkatesh L Murthy; Jason W D Hearn; Feng-Ming Kong; Gregory P Kalemkerian; James A Hayman; Randall K Ten Haken; Theodore S Lawrence; Matthew J Schipper; Shruti Jolly
Journal:  J Clin Oncol       Date:  2017-03-16       Impact factor: 44.544

5.  Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study.

Authors:  Kate Haslett; Kevin Franks; Gerard G Hanna; Susan Harden; Matthew Hatton; Stephen Harrow; Fiona McDonald; Linda Ashcroft; Sally Falk; Nicki Groom; Catherine Harris; Paula McCloskey; Philip Whitehurst; Neil Bayman; Corinne Faivre-Finn
Journal:  BMJ Open       Date:  2016-04-15       Impact factor: 2.692

6.  Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.

Authors:  S Teoh; F Fiorini; B George; K A Vallis; F Van den Heuvel
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.901

7.  Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.

Authors:  Kate Haslett; Neil Bayman; Kevin Franks; Nicki Groom; Susan V Harden; Catherine Harris; Gerard Hanna; Stephen Harrow; Matthew Hatton; Paula McCloskey; Fiona McDonald; W David Ryder; Corinne Faivre-Finn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-11-21       Impact factor: 7.038

8.  Rationale and early outcomes for the management of thymoma with proton therapy.

Authors:  He J Zhu; Bradford S Hoppe; Stella Flampouri; Debbie Louis; John Pirris; R Charles Nichols; Randal H Henderson; Catherine E Mercado
Journal:  Transl Lung Cancer Res       Date:  2018-04

9.  Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.

Authors:  Hannah E Bainbridge; Martin J Menten; Martin F Fast; Simeon Nill; Uwe Oelfke; Fiona McDonald
Journal:  Radiother Oncol       Date:  2017-10-04       Impact factor: 6.280

10.  Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer.

Authors:  Alexandra Hotca; Maria Thor; Joseph O Deasy; Andreas Rimner
Journal:  Clin Transl Radiat Oncol       Date:  2019-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.